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Abstract (250 words) 
A functioning placental renin-angiotensin system (RAS) appears necessary for uncomplicated 
pregnancy and is present during placentation, which occurs under low oxygen tensions. Placental 
RAS is increased in pre-eclampsia (PE), characterised by placental dysfunction, and elevated 
oxidative stress. We investigated the effect of high altitude (HA) hypoxia on the RAS and 
hypoxia-inducible factors (HIFs) by measuring mRNA and protein expression in term placentae 
from normotensive (NT) and PE women who delivered at sea-level or at above 3100m). A 
placental explant model of hypoxia-reoxygenation (hypoxia/reperfusion) was used to assess the 
impact of acute oxidative stress on the RAS and HIFs. 
Protein expression of prorenin (P=0.049), prorenin receptor (PRR; P=0.0004), angiotensin 
receptors (AT1R; P=0.006) and (AT2R; P=0.002) were all significantly higher in NT women at 
altitude despite mRNA expression being unaffected. In contrast, mRNA expression of all RAS 
components was significantly lower in PE at altitude than at sea-level yet protein expression of 
PRR, angiotensinogen (AGT) and AT1R were all increased. The increase in transcript and protein 
expression of all the HIFs and NADPH oxidase 4 seen in PE compared to NT at sea-level was 
blunted at high altitude. 
 
Experimentally-induced oxidative stress stimulated AGT mRNA (P=0.04) and protein (P=0.025). 
AT1R (r=0.77, P<0.001) and AT2R (r=0.81, P<0.001) mRNA were both significantly correlated 
with HIF-1β, whilst AT2R also correlated with HIF-1α (r=0.512, P<0.013). 
 
Our observations suggest that the placental RAS is responsive to changes in tissue oxygenation: 
this could be important in the interplay between reactive oxygen species as cell-signalling 
molecules for angiogenesis and hence placental development and function. 
 
 
Abbreviations: AGT, angiotensinogen; Ang II, angiotensin II; Ang IV, angiotensin IV; Ang (1-
7), angiotensin-(1-7); AT1R, angiotensin type 1 receptor; AT2R, angiotensin type 2 receptor; 
AT2AR, adenosine A2A receptor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HA, high 
altitude; HIF, hypoxia-inducible factor; NOX4, NADPH oxidase 4; H/R, hypoxia-reperfusion; 
NT, normotensive; MSU, midstream urine; PE, pre-eclampsia; PRR, prorenin receptor; RAS, 
renin–angiotensin system; ROS, reactive oxygen species; XO, xanthine oxidase.  
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Introduction 
In the early 20th century, Sir Joseph Barcroft (Barcroft, 1946) famously postulated that the fetus 
may be considered as ‘Everest in utero’  because of its development in a hypoxic environment, 
probably only experienced at the Earth’s highest point– the summit of Mt. Everest. Only relatively 
recently, arterial blood gases taken from climbers descending from this summit in 2007 have 
revealed just how astonishingly accurate this prediction turned out to be (West, 2009). 
The transition from acute hypoxia to hypoxic adaptation may involve the renin-angiotensin 
system (RAS), which has been known as a regulator of systemic blood pressure and vascular 
function for many decades (reviewed in (Nguyen Dinh Cat & Touyz, 2011; Farag et al., 2015) . 
Systemic RAS in male adults is activated by acute exposure to high altitude (HA) (Sun et al., 
2013), whereas exposure to chronic hypoxia, in rat models of human primary hypertension, the 
RAS is suppressed (Cervenka et al., 2015). The RAS has also been well researched in the context 
of hypertensive disorders of pregnancy such as  pre-eclampsia (PE) (Symonds et al., 1975; Irani & 
Xia, 2011; Mistry et al., 2013), a condition which has increased incidence at high altitude 
((Palmer et al., 1999; Keyes et al., 2003). 
However in recent years, it has become more evident that the RAS may play a significant role, not 
only in differing ways throughout pregnancy, but also in the early stages of placentation. 
Components such as the angiotensin receptors are expressed at very early stages of 
embryogenesis, when they may be responding to maternally-derived angiotensin II (AngII) 
(Pijacka et al., 2012); (Tebbs et al., 1999), in the placental syncytiotrophoblast and 
cytotrophoblast (Cooper et al., 1999); (Williams et al., 2010); prorenin and angiotensinogen 
(Marques et al., 2011; Pringle et al., 2011) as well as in the maternal decidua (Anton et al., 2009).  
Both Ang II and the biologically-active fragment Angiotensin IV (3-8) (Ang IV) promote the 
invasion and proliferation of trophoblasts (Williams et al., 2010) and angiogenesis in placental 
tissue (Pringle et al., 2011), thus supporting the establishment of a placental vasculature.  
Detailed knowledge on the process of implantation in humans is scarce, although the path from 
mother to the placenta must be established by the invasion of extravillous trophoblasts, starting 
from the tips of anchoring villi and intruding down into the inner third of the myometrium 
(Pijnenborg et al., 2011); (Huppertz et al., 2014). One fact is unequivocal: trophoblast invasion 
clearly correlates with oxygenation of the placenta (Huppertz et al., 2014). Initial reorganisation 
of the syncytiotrophoblast layer and proliferation of the underlying cytotrophoblasts occurs in the 
first 5 weeks after implantation under oxygen tensions below 20 mmHg (Rodesch et al., 1992); 
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(Jauniaux et al., 2000): these oxygen tensions in other tissues would be considered ‘hypoxic’ but 
are physiologically normal for establishment of the placenta. Extravillous trophoblast invasion 
into the maternal tissue starts at higher partial pressures of 40-50 mmHg (Jauniaux et al., 2000), 
after dissolution of endovascular trophoblast plugs within the spiral arteries enables the increase in 
maternal blood flow into the placenta. Direct in vivo oxygen measurements within the placental 
intervillous space are only available within the first 16 weeks (Jauniaux et al., 2000), but indirect 
approximations indicate that in the second half of normal pregnancy, oxygen tensions range 
between 30-40 mmHg (Huppertz et al., 2014). 
In normotensive (NT) pregnancy, placental growth is stimulated by a number of factors including 
adenosine, which promotes angiogenesis, proliferation, inflammation and protection against 
oxidative stress (Hasko & Cronstein, 2004). We have previously established that there is a strong 
positive association between the RAS and adenosine in first trimester placental tissue (Kurlak et 
al., 2015), when oxygen tensions are low (Rodesch et al., 1992). The stimulation of adenosine is a 
response to hypoxia (Poth et al., 2013) and therefore unsurprisingly placental adenosine receptor 
A2AR strongly correlates with HIF-1α (Kurlak et al., 2015). Is the RAS acting as a signal 
transduction regulator for both oxygen sensing and angiogenesis? In other cell systems such as 
human fibroblasts cooperativity, between hypoxia- and angiotensin-induced proliferative 
responses has already been observed (Krick et al., 2005), but a relationship between the RAS and 
low oxygen environment in the placenta has not yet been investigated. 
In the pathological pregnancy condition of pre-eclampsia (PE), defined as de novo hypertension 
after 20 weeks gestation with significant proteinuria (Brown et al., 2001; Tranquilli et al., 2013), 
it has previously been suggested  that the placental tissue is more hypoxic than in NT pregnancy. 
Since there are no direct measurements of intervillous oxygen tension beyond early second 
trimester, these assumptions have largely been based on evidence such as upregulation of global 
gene expression in PE showing similarities to in vitro and in vivo models of placental hypoxia 
(Soleymanlou et al., 2005) and increases in hypoxia-inducible factors (HIFs) (Zamudio et al., 
2007); (Rajakumar et al., 2008). These assumptions are being questioned  in light of up-to-date 
evidence (Huppertz et al., 2014), where placental metabolism in PE shows that there is no 
reduction in energy supplies as would be expected in chronic hypoxia (Bloxam et al., 1987). It has 
been proposed (Hung & Burton, 2006) that the absolute oxygen concentration in the intervillous 
space may not be critically important, but rather fluctuations in oxygen tension that may lead to 
tissue oxidative stress as indicated by rapid degeneration of syncytium (Watson et al., 1998). Each 
spiral artery delivers oxygenated blood to the centre of a placental lobule (Wigglesworth, 1969) 
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with fluctuations in intervillous blood flow during NT pregnancy. In pathological conditions such 
as PE, where there is reduced or absent dilation of the proximal end of the spiral arteries, flow 
may be even more intermittent. Sharp rises in oxygen tension within the lobule could induce 
excessive bursts of production of reactive oxygen species (ROS), which include free radicals such 
as superoxide anions, nitric oxide and hydroxyl radicals. Bursts of ROS production that 
overwhelm local antioxidant defences will result in oxidative stress. PE is characterised by both 
increased circulatory and placental oxidative stress (reviewed in (Goulopoulou & Davidge, 2015). 
There are several sources within the placental tissue that could generate ROS bursts, including 
mitochondria. These have been proposed as a source of the oxidative stress in PE, as demonstrated 
by swelling and loss of cristae, increased concentrations of malondialdehyde showing greater 
potential for lipid peroxidative damage (Wang & Walsh, 1998).  
The formation of excessive amounts of free radicals and hence failure of mitochondrial reduction-
oxidation balance have been tightly linked to dysregulation in the RAS (Vajapey et al., 2014).  
One of the main peptides generated from angiotensinogen (AGT) susbstrate is Ang II, which 
binds with equal affinity to its type 1 (AT1R) and type 2 (AT2R) receptors (de Gasparo et al., 
2000). The binding of Ang II to AT1R activates NADPH oxidase (NOX), which leads to 
increased generation of cytoplasmic ROS. This Ang II-AT1R-NADPH-ROS signal triggers the 
opening of mitochondrial potassium (KATP) channels and mitochondrial ROS production in a 
positive feedback loop (Vajapey et al., 2014). The maintenance of ROS balance means that the 
production of ROS needs to be matched with ROS scavenging mechanisms: Ang II has been 
implicated not only in activating ROS but also in decreasing the activity of scavenging enzymes 
(decreasing glutathione peroxidase, superoxide dismutase and catalase), thereby contributing even 
further to detrimental levels of ROS (Vajapey et al., 2014).  
Our group has already suggested a role for RAS components in the establishment of the placenta 
by demonstrating temporal changes in the Ang II receptors - AT1R, AT2R,  AT4R (the receptor 
for bioactive Ang IV  peptide) through gestation and a temporal relationship with the pro-oxidant 
enzymes – NADPH oxidase isoform (NOX4) and xanthine oxidase (XO) (Williams et al., 2010). 
Furthermore, the placental RAS is altered in PE with AT1R being more highly expressed in the 
placenta from women with PE and AT1R expression alsonegatively correlating with infant 
birthweight and placental gluthathione peroxidase 3(Mistry et al., 2013).  
Pregnancy at HA gives a unique opportunity to investigate a natural model of PE. The incidence 
of PE is three-fold greater in areas above 2500 m (Moore et al., 2011), where barometric pressure 
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falls from  760 mmHg at sea level where the PO2 of ambient air is 159 mmHg, to a barometric 
pressure of 537 mmHg at 3000 m. At such altitude the birthweights are smaller by an average of 
102 g/1000 m elevation, despite placental weights being comparable (Yung et al., 2012). On the 
basis of these considerations, we set out to investigate in this study (i) whether tissue-based RAS 
is activated by HA hypoxia by examining placentae from NT women who have delivered at HA 
compared to those who resided at sea-level before and throughout the pregnancy; (ii) to determine 
whether there is a further effect of PE on the RAS in placentae from PE women at altitude.  In 
addition (iii) we have tested the theory that oxidative stress induced by hypoxia/reperfusion (H/R) 
injury might be the activator of the RAS as opposed to hypoxia per se, by culturing term placental 
tissue explants in vitro, under differing conditions of hypoxia and oxidative species.  
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Methods 
Ethical approval 
All samples were collected following provision of informed, written consent conforming to the 
standards set by the Declaration of Helsinki, and all procedures were approved by the local ethics 
committee (Hospital Ethics Committee of the Nottingham University hospitals, University of 
Colorado Health Sciences Center (Aurora, CO, USA) and University College Hospital London 
(London, UK), and the Cambridge Local Research Ethics Committee). 
Subjects, selection criteria and sample collection 
NT control and PE placentae were collected from women at both sea-level and HA. PE was 
stringently defined as per the International Society for the Study of Hypertension in Pregnancy 
guidelines of a systolic blood pressure of 140 mm Hg or more and diastolic pressure (Korotkoff 
V) of 90 mm Hg or more on 2 occasions after 20 weeks gestation in a previously NT woman and 
proteinuria ≥300 mg/L, ≥500 mg/day or ≥2+ on dipstick analysis of midstream urine (MSU) if 24-
hour collection result was not available (Brown et al., 2001). Exclusion criteria included smoking, 
renal disease, cardiac disease, diabetes, chronic hypertension, pregnancy-induced hypertension, or 
any other complications of pregnancy, and known risk factors for these conditions. All placentae 
were from term deliveries, either by elective Caesarean section (CS) or spontaneous vaginal 
delivery (SVD). The HA placentae were collected at St. Vincent's General Hospital (Leadville, 
CO, USA; 3100 m) from stable, but recently migrant, populations of European descent. The sea-
level placentae were collected at the Rosie Hospital (Cambridge, UK) and, Nottingham University 
Hospitals (Nottingham, UK) and University College Hospital (London, UK). By the very nature 
of the collections, the subject numbers differed in the various parts of the study and will be 
specified with the results. 
Samples were obtained using a systematic random system by which the placenta was divided into 
5 areas (Hung et al., 2001a). Two full-thickness samples were taken from each area, washed in 
phosphate buffered saline (PBS) to remove excess blood contamination, snap-frozen in liquid 
nitrogen within 10 min of delivery, and then maintained at −80°C until further processed. Samples 
for immunohistochemistry were immediately submersed in formalin to be fixed for 12–24 h. After 
being treated with 70% ethanol for 24 h, placental samples were further dissected before being 
embedded in paraffin. 
Acute hypoxia experiments 
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Term placentae were obtained from NT pregnancies immediately after elective CS delivery before 
onset of labour as previously described (Hung et al., 2001b);(Hung et al., 2002). Briefly, villous 
samples (~40-50 mg wet weight) were taken midway between the chorionic and basal plates, from 
5-7 lobulae free of visible infarction, calcification, hematoma, or tears. After a brief wash in cold 
PBS, samples were placed in culture medium (Medium-199 with 25 mmol/L HEPES, Earles’ salts, 
and L-glutamine; Life Technologies Ltd., Paisley, UK) equilibrated with 95% N2/5% CO2 (BOC, 
Guildford, UK) in sealed glass bottles, and transferred to the laboratory on ice for individual 
experiments.  
After dissection, 6 pieces of villous tissue (∼5 to 10 mg) were cultured in individual Costar Netwell 
(24-mm diameter, 500-μm mesh; Corning) supports in 1.5 mL of culture medium.  A gas mixture 
of 10% O2/85% N2/5% CO2 was used as the normoxic condition, and the dissolved oxygen tension 
in the medium was 45-62 mm Hg. Conditions for hypoxia and H/R were established as previously 
described (Hung et al., 2001b). For H/R  experiments, villous tissues were cultured under hypoxic 
conditions (PO2 in medium = 12 - 16 mm Hg) at 37°C for 3 hours, then transferred to medium 
equilibrated with air/5% CO2 in a separate humidified chamber continuously flushed with air/5% 
CO2 for an additional 4 hours (PO2 in medium = 143 - 160 mm Hg). In control experiments, villous 
tissues were kept under either normoxic conditions throughout the 7-hour period with a change of 
medium at 3 hours. Additional samples were incubated under normoxic conditions with either 1 
mM hydrogen peroxide (H2O2) or vitamins C and E (1 mM for both). 
 
RNA extraction and cDNA synthesis 
Total RNA was extracted from a known amount of placental tissue (~100 mg) using QIAzol lysis 
reagent (Qiagen, Crawley, UK) as previously described (Mistry et al., 2011). RNA concentration 
and purity were verified spectrophotometrically using the Nanodrop ND-1000 (Nanodrop 
Technologies, Labtech, Ringmer, UK); all of the samples had an A260/A280 ratio >1.96. RNA (1 
μg) was reverse transcribed using the QuantiTect Reverse Transcription kit (Qiagen, Crawley, 
UK) in a Primus96 thermocycler (Peqlab Ltd, Fareham, UK).  
Quantitative real time Polymerase Chain Reaction (PCR) 
Real-time PCR was carried out using SYBR Green chemistry (2x QuantiFast SYBR Green, 
Qiagen, Crawley, UK) on a ABI7500 Fast (Life Technologies,UK) using the primers detailed in 
Table 1. Melt-curve analysis was performed to confirm the presence of one single product and 
non-template controls were run to assess contamination. The standard curve method was used to 
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quantify gene expression. Abundance data for the genes of interest were expressed following 
normalisation using GeNORM (http://medgen.ugent.be/~jvdesomp/genorm/), with 3 stably 
expressed housekeeping genes, suitable for human placental samples: GAPDH, β-2-microglobulin 
and β-actin (Murthi et al., 2008); (Kurlak et al., 2013) and expressed normalised to copy number. 
Immunohistochemical staining of RAS components and markers of hypoxia/oxidative stress 
Placental protein expression was analysed by immunohistochemistry. Serial sections of placental 
tissue were cut (5 µm) in the same orientation from paraffin-embedded tissue blocks (Sledge 
Microtome, Anglia Scientific, Norwich, UK) and mounted onto Superfrost plus glass microscope 
slides (Menzel-Glaser, Braunschweig, Germany). Before use, sections were dewaxed by 
immersion in xylene followed by rehydration in descending concentrations of alcohol (5 minutes 
each). 
Immunohistochemical staining was performed using the Dako Envision staining kits (Dako Ltd 
Germany). Eight rabbit and 2 mouse antibodies were used for immunostaining of paraffin-
embedded placental sections. The optimal dilutions and details of all antibodies used are shown in 
Table 2. Heat-induced epitope retrieval was achieved by heating in a citrate buffer (pH 6.0) using 
a microwave oven for 15 minutes (800 W), followed by incubation for 30 minutes in normal goat 
serum (Sigma-Aldrich, UK) to block nonspecific binding; slides were then incubated with primary 
antibodies overnight at 4°C. A negative control was performed for each test section by incubation 
with mouse or rabbit IgG as appropriate. Sections were dehydrated and cleared in ascending 
concentrations of alcohol and xylene before mounting in DPX (BDH, Poole, United Kingdom). 
For analysis of placental sections, digital images of 5 randomly selected, high-power (×400 
magnification) fields were captured on NIS-Elements F2.20 microscope (Nikon UK Ltd, UK). 
Protein expression was semi-quantitatively assessed (H-score) at x200 magnification (Nikon 
Eclipse II microscope) by two blinded observers (LOK & HDM), as described previously (Mistry 
et al., 2013). Between-observer agreement for H-scoring was excellent (kappa 0.97). A visual 
check was also performed to ensure accurate discrimination of immunolabeled regions. 
 
Statistical analysis 
All tests were performed using SPSS for Windows version 22 and GraphPad PRISM, version 6. 
Summary data are presented as means ± standard deviation (SD) or median and interquartile range 
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(IQR) as appropriate, the one-way ANOVA or Kruskal-Wallis tests followed by Gabriel’s or 
Mann-Whitney U post hoc tests were used depending on the distribution of the data, after testing 
using the Kolmogorov-Smirnov test. Correlations between the parameters were tested with a 
Spearman’s Rank test. The null hypothesis was rejected where P<0.05. The data from the in vitro 
culture experiments were evaluated using repeated measures analysis.  
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Results 
A. Ex vivo data 
(i). Placental RAS in NTwomen at HA 
mRNA measurements were available from 9 placentae collected at sea-level ( SVD: n = 4; CS: n 
= 5) and 8 at HA (SVD: n = 4; CS: n = 4). For the protein expression study, 16 placentae were 
collected at sea level n=16, (SVD: n=9; CS: n=7), and 8 at HA (SVD: n = 4; CS: n = 4). 
The mRNA expression of all RAS components was not significantly affected by altitude in NT 
women, although variation was higher for all components at HA (Fig. 1A). In contrast, the protein 
expression of prorenin (P = 0.049), prorenin receptor (PRR; P = 0.0004) and both AT1R (P = 
0.006) and AT2R (P = 0.002) were all significantly higher in NT placentae from HA (Fig. 1B), 
although expression of AGT was not different (P > 0.1). All proteins were confined to the outer 
layer of the villous syncytiotrophoblast. The ratio between prorenin and its receptor, PRR also 
rose significantly (P = 0.008), while that between the AT1R and AT2R was unchanged (P > 0.8). 
The type of delivery did not influence protein expression of any of the RAS components (P > 0.2 
to > 0.7) and therefore we did not consider mode of delivery as a confounder in further analyses. 
 
(ii). Placental RAS in women with PE at HA 
mRNA measurements were available from 19 placentae collected at sea-level (n = 11) and at HA 
(n = 8). Samples analysed for proteins included 6 collected at sea level and 5 at HA.   
The mRNA expression was significantly lower in PE women at HA, for all RAS components (Fig. 
2A) except the AT1R. By contrast with samples from NT women (Fig. 1A), the variability in 
mRNA expression was also markedly less. However, the protein expressions of PRR, AGT and 
AT1R were all increased in PE at altitude (Fig. 2B) although this only reached statistical 
significance for AGT and AT1R. 
 
 
 
Placental HIFs and NOX4 in NT and PE at altitude  
In the HA NT pregnancies, placental mRNA expression of all HIFs and NOX4 was unaffected by 
altitude (Fig. 3A). However, the protein expression of all the HIFs: HIF-1α (P < 0.001); HIF-1β 
   12 
 
(P < 0.001); HIF-2α (P = 0.04) as well as NOX4 (P = 0.001) was significantly raised in high 
altitude pregnancies (Fig.3B). The enzyme XO, was unaffected by altitude (data not shown). 
Immunohistochemical staining was localised to the syncytiotrophoblast cells and around the fetal 
vessels of the placental villi. 
The effect of altitude on the pattern of expression differed in the placentae from women with PE. 
Whereas there was no effect of altitude in the NT women, the mRNA expression of HIF-1α, HIF-
1β and NOX4 mRNA expression were all lowered at HA compared to the sea-level PE women (P 
< 0.001 for all; Fig. 3A). When comparing placentae from NT and PE women at sea-level, HIF-1α 
and NOX4 mRNA expression was markedly higher in the PE compared to NT (P = 0.01 and P = 
0.001 respectively). At HA, HIF-2α mRNA expression was lower in PE than NT (P = 0.003; Fig. 
3A).  
Protein expression was equally affected by altitude in the PE women: HIF-1α (P < 0.01); HIF-1β 
(P = 0.03); HIF-2α (P = 0.017) as well as NOX4 (P = 0.004) were significantly lower in high 
altitude pregnancies in women with PE (Fig. 3B). Xanthine oxidase protein expression was not 
markedly altered (data not shown). 
In HA samples, protein expression of HIF-1α (P = 0.001); HIF-1β (P = 0.001); HIF-2α (P = 
0.029) and NOX4 (P = 0.019) was significantly lower in women with PE as compared to NT 
women (Fig. 3B). 
B. In vitro data 
(i) In vitro explant culture under experimental oxidative stress conditions  
Due to the nature of the explant methodology, sample numbers in each of the treatment groups 
were 4-6 depending on availability of sufficient quality tissue.   
Experimental H/R treatment significantly only increased the mRNA expression of AGT (P = 0.04; 
Fig. 4A) compared to normoxic conditions. Protein expression followed the same pattern with 
only AGT enhanced (P = 0.025) with H/R treatment (Fig. 4B). Treatment with H2O2 under 
normoxic oxygen concentrations, and normoxia with added free radical scavengers (vitamins C 
and E), both, had no effect on AGT mRNA, although both H2O2 and H/R were associated with 
significantly-increased AGT protein expression (Fig. 4B). No other components of the RAS were 
significantly altered by any of the treatments.  
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The HIFs and antioxidant enzymes were also measured in these experiments, to establish whether 
hypoxia was being sensed within this model. There was no observable effect of these 
experimental conditions on either mRNA expression or protein expression, of any of the HIFs, 
NOX4, or XO. Interestingly, we identified strong positive correlations in gene expression between 
HIF-1β and both angiotensin receptors AT1R (r=0.77, P<0.001) and AT2R (r = 0.81, P < 0.001), 
but only AT2R also correlated with HIF-1α (r = 0.512, P < 0.013; Fig. 5). 
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Discussion 
Our aim was to investigate the effects of oxidative stress on the RAS in the human placenta, 
whether associated with the lower pO2 of HA chronic hypoxia, with the elevated tissue and 
circulatory chronic oxidative stress, which characterises PE, or with the acute experimental 
oxidative stress induced in vitro by a H/R insult. Our novel results demonstrate, for the first time 
that, components of the RAS are activated under these conditions, which components and to what 
extent is dependent on the nature of the insult. 
At altitude, the picture in these placentae from women chronically exposed to hypoxia is one of a 
generalised, significant increase in activity of the RAS, which, to our knowledge, has not been 
reported previously. The rise in PRR is statistically highly-significant, and the binding of (pro) 
renin to this receptor induces a 4-fold increase in its catalytic efficiency in the generation of 
angiotensin I (Ang I) from AGT (Nguyen et al., 2002). Thus, changes in PRR expression even 
without changes in AGT expression can have a substantial effect on the generation rate of Ang I, 
and hence Ang II. Furthermore, our results from the in vitro H/R model show a significant 
increase in both mRNA and protein expression of AGT supporting our premise that this element 
of the renin-angiotensin axis may be instrumental in ‘tuning’ the regulation of placental RAS in a 
redox environment. When oxidised, AGT is reacted with renin in the presence of the PRR, there is 
a 4-fold increase in the generation of Ang I (in addition to the 4-fold increase induced by the 
binding of prorenin to PRR), which does not occur if reduced AGT is reacted (Zhou et al., 2010). 
The hypoxia of altitude might be enough to increase the ratio of oxidised: reduced AGT and 
further stimulate the system. This appears to be corroborated by the rise in AGT observed after an 
acute hypoxic insult in the experimental model. Our observations suggest that this increase in 
AGT is not simply a reaction to lower oxygen tension per se but potentially relates to the 
increased oxidative stress induced by this model (Cindrova-Davies et al., 2007). We could only 
examine total AGT expression, as it is not yet possible to distinguish the oxidised and reduced 
forms immunohistochemically; total expression was not different at the two altitudes. 
Low concentrations of endogenous ROS are important in the activation of signalling pathways, 
which relate to hypoxia adaptation, such as genes involved in angiogenesis (e.g. vascular 
endothelial growth factor;VEGF),  where the promoter region has a binding site for H2O2 
(Oshikawa et al., 2010), which is essential for full activation of VEGF receptor 2 (VEGFR2).  
Accumulating evidence points towards the existence of direct interactions between Ang II and 
VEGF; a recent study has demonstrated that AT2R mediates the synergistic effect of a 
combination of Ang II and VEGF-A to promote differentiation of  bone marrow-derived 
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mesenchymal stem cells into endothelial cells (Ikhapoh et al., 2015). These authors suggest that 
AT2R could be critical to repair and regenerate damaged vascular endothelium. In other cell 
systems such as mouse Lewis lung carcinoma cells, hypoxia appears to upregulate ACE, Ang II, 
and AT1R. Most intriguingly, this regulation is diphasic: in the early phase, after 6 hrs hypoxia, 
AT1R protein is decreased, whilst AT2R protein is increased; yet if hypoxia is continued up to 24 
hrs, this effect is reversed, with AT1R protein significantly increased and AT2R decreased (Fan et 
al., 2014). Employing specific pharmacological inhibitors, these authors have concluded that this 
diphasic response may be due to a bi-directional control mechanism: hypoxia enhances the 
expression of AT1R and AT2R via increased Ang II, but elevated AT2R inhibits AT1R during the 
early stage and as hypoxia continues, elevated AT1R then inhibits AT2R expression. This may 
explain why neither the AT1R nor the AT2R were significantly altered in our H/R model. 
Nevertheless, the strong association, observed in this study, between both types of angiotensin 
receptors and the oxygen-sensing units (HIF-1β and HIF-1α) adds credence to the idea that these 
receptors are involved in the oxygen sensing mechanism of the syncytiotrophoblasts. AT2R may 
have a protective role in the repair of oxygenation-induced damage (Namsolleck et al., 2014), as 
seen in ischaemic stroke (McCarthy et al., 2009), myocardial ischaemic injury (Parlakpinar et al., 
2011; Park et al., 2013) and neurological pathologies (Sumners et al., 2013). 
By the same token, prorenin has also been shown to stimulate proliferation of retinal endothelial 
cells to an equivalent degree as that induced by VEGF and independently of Ang II (Zhu et al., 
2015). In pancreatic cancer cells, Ang II induces VEGF, through AT1R and ERK1/2 signalling 
(Anandanadesan et al., 2008). Studies in AGT-knockout mice report blunted hypoxia-induced 
endothelial progenitor cell function indicating that AGT is required for hypoxia-induced 
vasculogenesis (Choi et al., 2014). 
Since hypoxia stimulates the release of ROS, we postulated that the low oxygen partial pressure 
at altitude (HA hypoxia) would amplify the oxidative stress of PE, through increased production 
of ROS, and thus augment the stimulation of the RAS already observed in PE at sea-level. 
However, this stimulation did not occur: whereas mRNA expression of the RAS was unaffected 
in NT women at altitude (Fig. 1A), mRNA expression of the RAS was actually reduced in PE at 
altitude (Fig. 2A).  However, translation followed a very different pattern, showing increased 
translation (protein expression) in a majority of components of the RAS, in both NT and PE 
women at HA.   
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Concurrent analysis of the mRNA expression of the HIFs (Fig. 3) revealed that there were no 
detectable differences between sea-level and HA in the NT women; this agrees with previously 
published data (Tissot van Patot et al., 2004).  In contrast, the increases in HIF-1α, and NOX4 
observed in PE compared to NT women at sea-level were not observed in PE at HA; indeed, 
mRNA for HIF-1, HIF-1β and NOX4 were significantly lower in PE women at HA. Our 
protein data (Fig. 3) expand the study of Zamudio et al (Zamudio et al., 2007), which reported 
increases in the HIF-1α protein expression at HA in NT women. What is completely novel in our 
study is the observation that at HA, placental responses to oxygen deprivation in women with PE 
are completely blunted, as demonstrated by the lower mRNA and protein parameters of all the 
HIFs. Despite the low sample numbers, these observed differences are striking. This certainly 
begs the question – do pregnant women who develop PE at HA have an adaptive response to 
hypoxia that differs to that of NT women at HA?  Rajakumar et al (Rajakumar et al., 2008) 
suggest that impairment of protein degradation, rather than increased synthesis causes inadequate 
oxygen-dependent reduction of HIF-1α protein in PE and is supported by the fact that, in early-
onset PE placentae at least, there is decreased expression of the prolyl hydroxylases, PHD1 and 
PHD2 (Rolfo et al., 2010). Hence, molecular events leading to the formation of the HIF-
1α:VHL-ubiquitin ligase complex (Semenza, 2007), as well as proteasomal trypsin, 
chymotrypsin, and peptidyl glutamyl-like activities may be the focus of adaptation. In well-
oxygenated cells, PHDs hydroxylate the HIF-1α subunits, thereby targeting them for 
proteosomal degradation and resulting in a half-life of less than 5 minutes (Wang et al., 1995). 
PHDs are the key enzymes triggering HIF-1α desensitization, a feedback mechanism required to 
protect cells against necrotic cell death and thus to adapt them to chronic hypoxia (Ginouves et 
al., 2008). Whereas humans living at low altitudes ordinarily maintain low levels of HIF-1α and 
HIF-2α, through constitutive hydroxylation and degradation, upon ascent to high altitude, 
attenuated PHD2 hydroxylase activity due to hypoxia, leads to increased levels of HIF-1α and 
HIF-2α. Even so, the Tibetan population shows the strongest support for the hypothesis that 
multiple genes in the HIF pathway can be reconfigured in response to chronic hypoxia (Bigham 
& Lee, 2014); (Lorenzo et al., 2014):  the most convincing candidates for this reconfiguration 
being PHD2 and HIF-2α.  Tibetans are the first humans in whom a hypo-responsive HIF system 
has been demonstrated, and may represent an evolutionary resetting of the HIF system to operate 
within a hypoxic environment (Petousi et al., 2014). However, this may differentiate populations 
long-acclimatised to life at high altitude from those relatively-recently arrived, such as the 
inhabitants of Colorado included in this study. 
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As noted in the Introduction, spiral artery remodelling is a period of H/R insult. In order to 
explore the possibility that oxidative stress and not hypoxia per se is the driving force behind the 
activation of the RAS at HA and in PE, we used the fully-validated experimental model of H/R. In 
this model, increased oxidative stress is demonstrated by the increase in heat shock proteins 
Hsp27 and Hsp90, lipid peroxidation and formation of peroxynitrite (Cindrova-Davies et al., 
2007), localised mainly to the syncytiotrophoblast. The addition of the ROS scavengers, vitamins 
C and E significantly reduces markers of oxidative stress in the H/R-treated samples. Under these 
induced acute conditions of oxidative stress, our study reveals a more specific stimulation of the 
RAS, as seen by increased mRNA and protein expression of AGT only (Fig. 4).  The addition of 
vitamins C and E diminishes this increase, although this is not statistically significant, possibly 
due to the small sample sizes. Nonetheless, this reversal may suggest that the production of AGT 
is specifically sensitive to the redox environment (see also above). The fact that other RAS 
components were not increased by the acute oxidative stress of these experimental conditions 
implies that their generalised stimulation at HA may be a response to the chronically-reduced 
oxygen tensions. This is supported by the fact that in a mouse model of alveolar hypoxia, such as 
may occur in pulmonary diseases (e.g chronic obstructive pulmonary disease), the RAS is 
stimulated by the low PO2 (Gonzalez & Wood, 2010) and it is the activation of  NADPH oxidase 
by the RAS that leads to an inflammatory response. However, if the animals remain under 
hypoxic conditions  for several days, the inflammation resolves and exposure to lower PO2 does 
not elicit further inflammation, suggesting that the vascular endothelium has "acclimatised" to 
hypoxia (Gonzalez & Wood, 2010). Furthermore, in human lung fibroblast cells, hypoxia directly 
activates the RAS to induce collagen type I expression, mediated by NF-κB signalling, which in 
turn activates AT1R expression (Liu et al., 2013).   
Previously, using the different methodology of  Western blotting to measure protein in term villi, 
H/R was found to stimulate  HIF-1α in this model (Cindrova-Davies, 2009). Using the semi-
quantitative method of immunohistochemical scoring, we did not detect this stimulation. 
Likewise, use of H2O2 to mimic the effect of oxygen in acutely lowering HIF-1α, did not have this 
effect in our placental explants. This discrepancy may be due to differences in methodological 
sensitivity. 
Hypoxia cannot be merely defined by just the prevailing oxygen tension (Cindrova-Davies et al., 
2015), but must be related to the metabolic demands of the tissue. As Barcroft himself said 
“oxygen -is- but one of the proximate principles of nourishment” (Young, 1992). The placenta is 
an extremely metabolically active tissue (Carter, 2000; Illsley et al., 2010). Oxygen sensing is of 
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fundamental importance to all cells as oxygen consumption is required for ATP generation (Guzy 
& Schumacker, 2006).  In tissue such as the placenta, which is exposed not only to altered oxygen 
concentrations, and H/R insults during development, but also within its own lobule structures, 
oxygen sensing is critical in order to stimulate gene expression and transcription of genes relating 
to growth processes, including angiogenesis. An ability to control oxygen sensing mechanisms 
using molecules, which do not disrupt oxygen consumption, would have a profound impact on a 
diverse range of pathologies. We have here described such a potential system. 
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Table 1. Details of primers used in qPCR. 
Gene 
Accession 
number 
                 Primers 
Length 
(bp) 
PRR 
 NM 
5’ cctcattaggaagacaaggactatcc 3’ 
50 
5’ gggttcttcgcttgttttgc 3’ 
 
Prorenin 
NM 
5’ ccacctcctccgtgatcct 3’ 
46 5’ gcggatagtactgggtgtccat 3’ 
 
AGT 
NM_000029  
5` ccccagtctgagatggctc 3` 
117 5` gacgaggtggaaggggtgta 3` 
 
AT1R NM_004835 
5’ ggctattgttcacccatgaagt 3’ 
177 5’ tgggactcataatggaaagcac 3’ 
 
AT2R 
NM_000686 
5’ tatggcctgtttgtcctcattg 3’ 
115 5’ ccattgggcatatttctcaggt 3’ 
 
HIF1α 
NM_ 181054 
5’ atccatgtgaccatgaggaaatg 3’ 
125 5’ tcggctagttagggtacacttc 3’ 
 
HIF1β 
NM_ 001197325 
5’ tgactcctgttttgaaccagc 3’ 
95 5’ ctgctcacgaagtttatccacat 3’ 
 
HIF2α 
NM_ 001430 
5’ ggacttacacaggtggagcta 3’ 
5’ tctcacgaatctcctcatggt 3’ 
 
79 
NOX4 
NM_016931.3 
5’ tgaactatgaggtcagcctctg 3’ 
107 5’ aagcttgtatggtttccagtcat 3’ 
 
GAPDH 
NM_002046.3 
5’ ggaagcttgtcatcaatggaa 3’ 
5’ tggactccacgacgtactca 3’ 
 
102 
Β-Actin 
NM_001101.2 
5’ ccaaccgcgagaagatga 3’ 
5’ ccagaggcgtacaggatag 3’ 
 
97 
B2M 
NM_004048.2 
5’ cttatgcacgcttaactatcttaacaa 3’ 
5’ taggagggctggcaacttag 3’ 
 
127 
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 Table 2. Product descriptions and concentrations for immunohistochemistry 
Product name/Description  Concentration 
(mg/mL) 
PRR Anti- ATP6AP2 - Sigma Prestige, 
HPA003156.  
Rabbit polyclonal 
1.8 
Prorenin Anti-prorenin –Abcam, ab82450. 
Mouse monoclonal 
8.35 (1 in 200) 
AGT Anti-AGT – Sigma Prestige, HPA0031557.  
Rabbit polyclonal 
0.26 
AT1R Anti-AT1R – Abcam, ab9391.  
Mouse monoclonal 
80 
AT2R Anti-AT2R - Abcam, ab19134 
Rabbit ployclonal 
5.2 
HIF1α Anti- HIF1α – Sigma Prestige, HPA0031557 
Rabbit polyclonal 
1 in 200 
HIF1β Anti- Arnt – Aviva Systems Biology, 
ARP30979. Rabbit polyclonal 
1:1000 
HIF2α Anti-EPAS1 - Aviva Systems Biology, 
ARP32253. Rabbit polyclonal 
1:200 
NOX4 Anti-NOX4 - Abcam, ab133303.  
Rabbit polyclonal 
1:500 
XDH Anti-XDH - Aviva systems biology 
OAAB05869. Rabbit polyclonal 
1:500 
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Figure Legends 
Figure 1: A) Normalised mRNA expression (copy number) of all RAS components in placentae 
from normotensive controls residing and delivering at sea level (n = 9) or at high altitude (n = 8). 
B) Placental protein expression and localisation of RAS components from normotensive controls 
residing and delivering at sea level (n = 16) or at high altitude (n = 8). Boxplots represent median 
[interquartile range]; *P<0.05; **P<0.001; ***P<0.0001. Positive staining was localised mainly 
in syncytiotrophoblasts (black arrows). All photomicrographs taken at x400 magnification; 
positive staining is shown in brown. PRR: prorenin receptor; AGT: angiotensinogen; AT1R/2R: 
angiotensin receptors type 1 and 2. 
Figure 2: A) Normalised mRNA expression (copy number) of all RAS components in placentae 
from pre-eclamptic women residing and delivering at sea level (n = 11) or at high altitude (n = 8). 
B) Placental protein expression and localisation of RAS components from pre-eclamptic women 
residing and delivering at sea level (n = 6) or at high altitude (n = 5). Boxplots represent median 
[interquartile range]; **P<0.001; ***P<0.0001. Positive staining was localised mainly in 
syncytiotrophoblasts (black arrows). All photomicrographs taken at x400 magnification; positive 
staining is shown in brown. PRR: prorenin receptor; AGT: angiotensinogen; AT1R/2R: 
angiotensin receptors type 1 and 2. 
Figure 3: A) Normalised mRNA expression (copy number) of all hypoxia-inducible factor (HIF) 
components and NADPH oxidase (NOX4) in placentae from normotensive controls (NT) and pre-
eclampsia (PE) residing and delivering at sea level or at high altitude. B) Placental protein 
expression and localisation of HIF components and NOX4 from NT and PE women residing and 
delivering at sea level or at high altitude. Boxplots represent median [interquartile range]; 
*P<0.05; **P<0.001; ***P<0.0001. Positive staining was localised mainly in 
syncytiotrophoblasts (black rarrows), with some staining around fetal vessels (red arrows). All 
photomicrographs taken at x400 magnification; positive staining is shown in brown.  
Figure 4: Placental angiotensinogen A) mRNA and B) protein expression of term placental 
explants (n = 4-6) following incubation in normoxic conditions; following hydrogen peroxide 
(H2O2); after hypoxia/reperfusion (H/R) or with added free radical scavengers vitamins C and E 
(vitamins). Data analysed using repeated measures analysis and are represented at mean ± 
standard deviations; **P<0.001. Positive staining was localised mainly in syncytiotrophoblasts 
(black arrows). All photomicrographs taken at x400 magnification; positive staining is shown in 
brown. AGT: angiotensinogen. 
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Figure 5: Scatter plots demonstrating associations in placental mRNA expression of AT1R, 
AT2R, HIF-1β and HIF-α. HIF-1β strongly correlated with both AT1R (r= 0.77; P<0.001) and 
AT2R (r = 0.81; P <0.001) under all oxygenation conditions. AT2R also correlated with HIF-1α (r 
= 0.512; P < 0.01). 
 
 
